Logo For Seattle Genetics Pages on BioPortfolio:

BioPortfolio - Seattle Genetics
Press Releases on Seattle Genetics: BioPortfolio Logo. Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight
...
http://www.bioportfolio.com/biocorporate/9307-Seattle_Geneti...

Biotechnology News Seattle Genetics Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Seattle Genetics - Profile
View the current Seattle Genetics Page on BioPortfolio.com .... the option to add a corporate logo. • the creation of high value URL links back to your ...
http://www.bioportfolio.com/biocorporate/9307-Seattle%2BGene...

BioPortfolio Biotechnology BioNews : live article
Seattle Genetics Reports Second Quarter 2007 Financial Results and Highlights ... As of June 30, 2007, Seattle Genetics had $132.2 million in cash and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotechnology News Genetics Search
Seattle Genetics Bearish Technical Alert - Trend Down 14.6% More .upCom2 UPCOMING EVENTS Learn new strategies, how to trade in this market, and the
stocks ...
http://www.bioportfolio.co.uk/Genetics-news.htm...

BioPortfolio - Genetics
BioNews Results for Genetics: RSS Logo, BioPortfolio Logo. Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results
...
http://www.bioportfolio.com/indepth/Genetics.html...

Biotechnology News Lexicon Genetics Search
Seattle Genetics, Inc announced the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of
monoclonal ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Lymphoma Large-Cell Diffuse - InDepth
Seattle Genetics Announces Discontinuation Of Dacetuzumab Phase IIb Diffuse ... Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse ...
http://www.bioportfolio.com/indepth/Lymphoma_Large-Cell_Diff...

Biotechnology News Lymphoma Large-Cell Ki-1 Search
Seattle Genetics Announces Discontinuation Of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Tri Seattle Genetics, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Results from other life science and pharmaceutical sites:

Seattle Genetics, Inc. - Google Finance
Get the latest on Seattle Genetics, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:SGEN...

SGEN: Profile for Seattle Genetics, Inc. - Yahoo! Finance
See the company profile for Seattle Genetics, Inc. (SGEN) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/s/sgen.html...

BioSpace - Seattle Genetics, Inc. News, Search Jobs, Events
At Seattle Genetics, we are committed to developing innovative antibody-based therapies that improve clinical outcomes for patients with cancer and ...
http://www.biospace.com/company_profile.aspx?CompanyId=3510...

Seattle Genetics Inc. - Company Profile - BioCentury
Seattle Genetics' detailed financials; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma
industry ...
http://www.biocentury.com/companies/Seattle_Genetics_Inc?utm...

Technology evaluation: SGN-15, Seattle Genetics Inc.
Seattle Genetics is developing SGN-15 (BMS-182248, BR96-DOX), a monoclonal ... Seattle Genetics licensed SGN-15 from BMS in April 1999 [283767]. ...
http://www.ncbi.nlm.nih.gov/pubmed/11497354...

Seattle Genetics Highlights Pipeline Progress and Reports Third ...
22 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) today reported financial results for the third quarter and nine ...
http://biz.yahoo.com/bw/091022/20091022006387.html?.v=1...

Genentech: Newsroom: Press Releases: News Release January 8, 2007
8 Jan 2007 ... Genentech and Seattle Genetics Announce Exclusive Global Licensing ... Seattle Genetics to Hold Conference Call Today at 4:30 p.m. ET -- ...
http://www.gene.com/gene/news/press-releases/display.do?meth...

Seattle Genetics to Present at Upcoming Investor Conferences ...
27 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) announced today that management will present at two upcoming ...
http://biz.yahoo.com/bw/091027/20091027006241.html?.v=1...

News: Seattle Genetics Shutters B-Cell Lymphoma Program.
5 Oct 2009 ... Dacetuzumab is a humanized mAb that targets the CD40 antigen, which is expressed on most B lineage hematologic malignancies as well as some ...
http://www.genengnews.com/news/bnitem.aspx?name=64625433...

Live Call: Seattle Genetics Earnings Conference Call (Q3 2009 ...
Seattle Genetics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the ...
http://biz.yahoo.com/cc/4/107924.html...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.